CCL5 and COVID-19: In a follow-up study testing COVID-19 patients for 34 inflammatory-related substances, patients with mild symptoms showed higher levels of chemokine RANTES (CCL5), while patients with later-stage disease had significant increases in cytokines such as interleukin (IL) 6 and interferon-γ (IFN-γ) (70).